Choose the brand aligned with your industry so we can best serve your needs.
For researchers, scientists, and technical professionals: Your one-stop shop for the complete range of laboratory, production, and safety products and services.
(R)-omeprazole sodium is the R-enantiomer of omeprazole supplied as the sodium salt. It is a gastric acid-resistant proton pump inhibitor used as a research reference standard to study gastric acid secretion and CYP2C19-mediated metabolism. The compound is provided with high chemical and enantiomeric purity for analytical and pharmacology studies.
Molecular formula: C17H18N3NaO3S.
Molecular weight: 367.4 g/mol.
Purity: 98.1% (reported 98.07%).
Enantiomeric excess: 99.84%.
Function: reversible and metabolism-dependent inhibitor of CYP2C19.
Intended use: reference standard and research compound for pharmacology and metabolism studies.
Availability: includes small-scale 10 mg quantities suitable for analytical work.
Encompass Procurement Services Non-distribution item offered as a customer accommodation; additional freight charges may apply. Learn More
Omeprazole (73590-58-6) is a small-molecule inhibitor targeting H K -ATPase an enzyme essential for gastric acid secretion It is designed to inhibit the proton pump thereby reducing active transport of H ions into the gastric lumen Omeprazole exerts its biological activity primarily through irreversible binding to the H K -ATPase enzyme In in vitro studies Omeprazole demonstrates inhibitory activity with an IC value of approximately 5 8 M against purified H K -ATPase and an IC of 0 16 M in assays evaluating histamine-induced gastric acid production Based on these pharmacological properties Omeprazole holds research potential in the investigation of acid-mediated gastrointestinal conditions and related pathways
Encompass Procurement Services Non-distribution item offered as a customer accommodation; additional freight charges may apply. Learn More
Omeprazole Sodium is the sodium salt form of omeprazole which is a proton pump inhibitor and suppresses gastric acid secretion Omeprazole Sodium is a metabolism-dependent inhibitor (MDI) of CYP2C19
Encompass Procurement Services Non-distribution item offered as a customer accommodation; additional freight charges may apply. Learn More